Pharmaceutical
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Strength
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Pack Size
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Form
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Source
European Medicines Agency
Safety Profile
Contraindications
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Side Effects
Obiltoxaximab SFL : Orphan maintenance assessment report (initial authorisation)
Scan this QR code to access this page quickly on your mobile device.